EPIDEMIOLOGY OF IDDM IN BLACKS
黑人 IDDM 的流行病学
基本信息
- 批准号:6107394
- 负责人:
- 金额:$ 2.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 1999-09-29
- 项目状态:已结题
- 来源:
- 关键词:African American MHC class II antigen adolescence (12-20) alleles arginine aspartate blood chemistry case history clinical research diabetes mellitus genetics disease /disorder proneness /risk epidemiology gene expression gene mutation genetic markers genetic polymorphism genotype geographic site histocompatibility gene human genetic material tag human subject insulin dependent diabetes mellitus patient /disease registry racial /ethnic difference statistics /biometry
项目摘要
The objective of this study is to determine if the absence of apartic acid
at position 57 of the HLA-DObeta chain and presence of arginine at position
52 of the HLA-DOalpha chain is as strong of a genetic marker in African
Americans for IDDM as it is in Caucasians. There appears to be a 5-fold
difference in IDDM risk among African Americans residing in various areas
of the U.S. The variations seen may be due to the presence or absence of
these genetic markers which may be related to the degree of Caucasian
admixture in African Americans across the U.S. It is important to
establish a population-based diabetes registry to characterized the genetic
susceptibility of IDDM as it relates to HLA alleles. Washington, D.C.
provides an unique opportunity to examine incidence data and genetic risk
factors associated with IDDM in African Americans because of the large
percentage of them residing in the area. With an understanding of the
genetic risks of IDDM in African Americans, preventive strategies can be
more effectively implemented.
The specific aims of this project are to: (1) determine the incidence of
IDDM from 1990 to 1999 among African American children les than the age of
15 years from Washington, D.C., (2) determine the degree to which the
molecular polymorphisms of HLA class II genes are associated with IDDM
susceptibility among African Americans from Washington, D.C., (3) evaluate
the genotype-specific IDDM incidence rates associated with HLA class II
susceptibility genes, and (4) compare the genotype distributions and the
genotype specific IDDM incidence rates among African Americans from
Washington, D.C. with established registries in the U.S.
本研究的目的是确定是否缺乏天冬氨酸
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GAIL L NUNLEE-BLAND其他文献
GAIL L NUNLEE-BLAND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GAIL L NUNLEE-BLAND', 18)}}的其他基金
相似海外基金
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10618790 - 财政年份:2021
- 资助金额:
$ 2.46万 - 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10392325 - 财政年份:2021
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
- 批准号:
10674177 - 财政年份:2021
- 资助金额:
$ 2.46万 - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8360306 - 财政年份:2011
- 资助金额:
$ 2.46万 - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8167705 - 财政年份:2010
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
8131116 - 财政年份:2007
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7321929 - 财政年份:2007
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7673392 - 财政年份:2007
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7483748 - 财政年份:2007
- 资助金额:
$ 2.46万 - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7907767 - 财政年份:2007
- 资助金额:
$ 2.46万 - 项目类别: